Michael F. Mazurek - Concepedia

Author

Michael F. Mazurek

Massachusetts General Hospital

Also Known As

M. F. Mazurek, MICHAEL F. MAZUREK, Michael F Mazurek, Michael F. Mazurek, Michael Mazurek

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Harvard University McMaster University Medical Centre McMaster University Hamilton Health Sciences

About

Michael F. Mazurek is an author at Massachusetts General Hospital specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	2.2K
2	Social Sciences	5	5	133
3	Health Sciences	3	3	172
4	Natural Sciences	1	1	1.3K
5	Biochemistry	1	1	1.3K

Michael F. Mazurek

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid M. Flint Beal, Neil W. Kowall, David W. Ellison, Nature BiochemistryNatural SciencesQuinolinic AcidMolecular BiologyNeurochemical Characteristics	1986	1.3K
Reduced Numbers of Somatostatin Receptors in the Cerebral Cortex in Alzheimer's Disease M. Flint Beal, Michael F. Mazurek, Vinh T. Tran, Science Brain FunctionNeurochemical BiomarkersSomatostatin Receptor ConcentrationsNeuroinflammationAlzheimer's Disease	1985	251
Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease M. Flint Beal, Michael F. Mazurek, Geetinder K. Chattha, Annals of Neurology	1986	159
A postmortem study of amino acid neurotransmitters in Alzheimer's disease David W. Ellison, M. Flint Beal, Michael F. Mazurek, Annals of Neurology	1986	138
The Treatment of Neuroleptic Malignant Syndrome are Dantrolene and Bromocriptine Useful Adjuncts to Supportive Care? Patricia I. Rosebush, Thomas E. Stewart, Michael F. Mazurek The British Journal of Psychiatry Neuro-oncologyProlonged CourseNeuroleptic Malignant SyndromeSymptomatic TreatmentPharmacology	1991	125
Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidone Patricia I. Rosebush, Michael F. Mazurek Neurology	1999	120
Widespread reduction of somatostatin‐like immunoreactivity in the cerebral cortex in Alzheimer's disease M. Flint Beal, Michael F. Mazurek, Clive N. Svendsen, Annals of Neurology	1986	104
Catatonia After Benzodiazepine Withdrawal Patricia I. Rosebush, Michael F. Mazurek Journal of Clinical Psychopharmacology	1996	89
Somatostatin and neuropeptide Y concentrations in pathologically graded cases of huntington's disease M. Flint Beal, Michael F. Mazurek, David W. Ellison, Annals of Neurology	1988	87
Substance P‐like immunoreactivity is reduced in Alzheimer's disease cerebral cortex M. Flint Beal, Michael F. Mazurek Neurology	1987	86

Page 1